Dequest 2015 en es it fr

Dequest 2015 Brand names, Dequest 2015 Analogs

Dequest 2015 Brand Names Mixture

  • No information avaliable

Dequest 2015 Chemical_Formula


Dequest 2015 RX_link

Dequest 2015 fda sheet

Dequest 2015 msds (material safety sheet)

Dequest 2015 Synthesis Reference

No information avaliable

Dequest 2015 Molecular Weight

391.46 g/mol

Dequest 2015 Melting Point

No information avaliable

Dequest 2015 H2O Solubility

10 mg/L

Dequest 2015 State


Dequest 2015 LogP


Dequest 2015 Dosage Forms

Tablets (100 mg)

Dequest 2015 Indication

For symptomatic relief of dysuria, urgency, nocturia, suprapubic pain, frequency and incontinence as may occur in cystitis, prostatitis, urethritis, urethrocystitis/urethrotrigonitis.

Dequest 2015 Pharmacology

Flavoxate is a spasmolytic flavone derivative that acts by relaxing the smooth muscle in the urinary tract. Flavoxate is a competitive muscarinic receptor antagonist indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and urinary frequency. Muscarinic receptors play an important role in several major cholin-ergically mediated functions, including contractions of urinary bladder smooth muscle and stimulation of salivary secretion.

Dequest 2015 Absorption

Well absorbed from gastrointestinal tract.

Dequest 2015 side effects and Toxicity

The oral LD50 for flavoxate HCl in rats is 4273 mg/kg. The oral LD50 for flavoxate HCl in mice is 1837 mg/kg. Symptoms of overdose include convulsions, decreased ability to sweat, (warm, red skin, dry mouth, and increased body temperature), hallucinations, increased heart rate and blood pressure, and mental confusion.

Dequest 2015 Patient Information

Dequest 2015 Organisms Affected

Humans and other mammals